The Plus Pills study, led by Professor Bekker, is a part of a three-part study examining PrEP use in different groups. PrEP, which stands for PreExposure Prophylaxis, is an HIV prevention drug that can be taken by HIV-negative people to protect them from infection. This wonder-drug is a game changer in the fight to end…
DetailsPrEP is an everyday pill that an HIV negative person can take to prevent getting HIV. Consistent use is essential for protection. Since PrEP is still a relatively new advancement in HIV prevention technology, there are still a lot of concerns and misconceptions around it. Fortunately, there has been a flurry of research in the…
DetailsMen who have sex with men (MSM) are a population at high risk of HIV infection. In order to end HIV, we need targeted prevention strategies for this key population and the Sibanye study has been researching just that. The Sibanye study recorded the uptake of a package of HIV prevention tools in MSM in sites…
DetailsThis week, we were fortunate to have a visit from Sabine Van Elsland from the Desmond and Leah Tutu Legacy Foundation and VU University, who spoke about her research involving HIV positive children and how they respond to HIV treatment. Getting antiretroviral therapy (ART) to youths is one challenge, however, that is only the first…
DetailsThe International AIDS Symposium (IAS) Conference 2017 was a wealth of cutting edge research and discussion on HIV and AIDS, and the representatives from the Desmond Tutu HIV Foundation (DTHF) were no exception. Opening the conference was our own Prof Linda-Gail Bekker, the IAS President and International Scientific Chair of IAS 2017. Bekker spoke about…
DetailsIt was a delight to have a two-for-one research meeting with Ndumiso Madubela and Caroline Reid. Madubela discussed his PhD research outline looking at how men in high HIV burden communities engage with their local health services. Reid discussed her master’s research in science journalism and outlined the popular science journalism process. Women bear a…
DetailsThe IAS2017 Conference on HIV Science held in Paris in July highlighted the progress made internationally to eradicate AIDS. But it also emphasised that we cannot be complacent and we need to roll up our sleeves to maintain momentum. Nearly 8000 researchers, advocates and policy makers came together to demonstrate that the science that comes…
DetailsThe Desmond Tutu HIV Foundation invites staff of governmental & non-governmental organizations working at national, provincial & district levels to the Adolescent & Youth Health Policy Short-Course. The short course for health training takes place from the 11-15 September 2017 at The President Hotel in Cape Town, South Africa. The short-course will involve a five-day residential…
Details“It is in your hands to make of the world a better place.” This quote by Nelson Mandela encapsulates the feeling of Mandela Day. Commemorating his birthday, everyone is encouraged to celebrate by taking some action against poverty and serving the public for 67 minutes in some way. The Desmond Tutu HIV foundation took this…
DetailsIAVI #YOUTHTALK Workshop 9th/10th May 2017 For the second year, the International AIDS Vaccine Initiative (IAVI) partnered with us to host an exciting and informative research workshop at the River Club Conference Centre. We were delighted to welcome IAVI representatives from Kenya, Rwanda, and Uganda and many other local organisations. Research has shown that unless new HIV infections among…
Details
